Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model.

Wang, Biao; Wu, Shu-Ming; Wang, Tao; Liu, Kai; Zhang, Gong; Zhang, Xi-Quan; Yu, Jian-Hua; Liu, Chuan-Zhen; Fang, Chang-Cun

Wang, Biao; Wu, Shu-Ming; Wang, Tao; Liu, Kai; Zhang, Gong; Zhang, Xi-Quan; Yu, Jian-Hua; Liu, Chuan-Zhen; Fang, Chang-Cun.

Affiliation

Wang B; Department of Cardiovascular Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China.

Chin Med J (Engl) ; 125(10): 1753-9, 2012 May.

Article in En | MEDLINE | ID: mdl-22800895

Subject(s)

Blood Coagulation/drug effects; Lipopolysaccharides/pharmacology; Mesenchymal Stem Cells/cytology; Alanine Transaminase/metabolism; Animals; Bone Marrow Cells/cytology; Creatinine/metabolism; Interferon-gamma/metabolism; Interleukin-1beta/metabolism; Male; Mesenchymal Stem Cells/physiology; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha/metabolism

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Blood Coagulation / Lipopolysaccharides / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Animals Language: En Year: 2012 Type: Article

Search on Google

XML

PubMed Links